Skip to content

Clinical trials

Terminated Overweight trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Terminated Country / region: United States Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20072
20082
20091
20103
20112
20125
20151
20166
20175
20184
20196
20202
20212
20221
20233
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
USDA Grand Forks Human Nutrition Research Center5
Boston Children's Hospital2
Columbia University2
Eli Lilly and Company2
Stanford University2
USDA, Western Human Nutrition Research Center2
University of Pittsburgh2
Washington University School of Medicine2
Yale University2
Alnylam Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight56
Obesity45
Diabetes Mellitus, Type 29
Weight Loss6
Insulin Resistance5
Metabolic Syndrome5
Pediatric Obesity4
Diabetes Mellitus3
Dyslipidemias3
Hypertension3

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.